
-
QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of Omicron variantQIAGEN announced its PCR tests remain accurate and effective in detecting SARS-CoV-2 infections
-
Understanding the impact on test resultsStay up to date on our continuous surveillance assessing the impact of mutations on assay sensitivity. (Updated March 2022)
-
Innovation-led NGS solutions and integrated bioinformaticsGain greater insights into the epidemiology of SARS-CoV-2 with a full spectrum of NGS solutions and integrated bioinformatics pipelines.
-
SARS-CoV-2 variants genotyping – new toolsThese qPCR genotyping assays are wet-lab verified using the QIAprep& Viral RNA UM Kit and can rapidly detect the variants of concern, including the new Omicron/B.1.1.529, generating results on the same day.
-
Testing during respiratory seasonWith the emergence of the Omicron variant, what can infectious disease experts do to help their patients this respiratory season? Find out in our article..
icon-support
How can we support your lab?
Reach a specialist about SARS-CoV-2 resources.
möLab GmbH is the manufacturer of the mö-screen Corona Antigen Test. QIAGEN is a distributor.
For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor.
For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor.